Comprehensive Blood & Cancer Center(CBCC) is a state of the art Cancer Specialty center in Bakersfield CBCC's philosophy is to provide compassionate cancer care delivery under one roof despite the convolution of cancer treatment and disgnosis modalities. CBCC has been No.1 accrual site for UCLA, Bristol Myers Squibb, and was the fiirst research site in the Western United State for Erbitix, a novel antibody drugs for colon cancer.  <more>